This process is triggered by neoangiogenetic factors, which are produced from the BMSC, [such as vascular endothelial growth factor (VEGF), basic fibroblasr growth factor (b-FGF) and TGF-β, and from the myeloma cells themselves (such as VEGF, IL-8 and TGF-β). Here, VEGFA is linked to plasma cell myeloma.